Crane Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Crane Co. on July 24, 2017. The filing primarily serves to announce the Company's results of operations for the quarter ended June 30, 2017, and to provide detailed updates regarding its asbestos liability, claims activity, and litigation status. The Company is incorporated in Delaware and maintains its principal executive offices in Stamford, Connecticut.
Key Financial Metrics: Asbestos Liability and Costs
The filing provides specific financial data related to asbestos claims, though it does not contain general revenue, profit, or cash flow figures for the Company's core operations (referenced in Exhibit 99.1).
- Total Asbestos Liability: $653 million as of June 30, 2017 (down from $696 million as of December 31, 2016).
- Current Portion of Liability: $71 million, representing estimated costs to be paid within the next twelve months.
- Insurance Receivable Asset: $129 million as of June 30, 2017 (down from $143 million as of December 31, 2016).
- Cumulative Resolved Claims: Approximately 129,000 claims resolved through June 30, 2017, with total settlement costs of approximately $509 million.
- Average Settlement Cost: Approximately $4,000 per resolved claim cumulatively.
Material Changes and Claims Activity
The filing details significant activity in asbestos claims and litigation outcomes for the periods ended June 30, 2017.
- Claims Volume: As of June 30, 2017, there were 31,980 pending claims, a decrease from 35,560 at the beginning of the quarter. New claims filed in the quarter were 684, while dismissals totaled 3,937 and settlements were 327.
- Costs Incurred (Six Months Ended June 30, 2017):
- Settlement/Indemnity costs: $25.8 million.
- Defense costs: $19.0 million.
- Total costs incurred: $44.8 million (compared to $37.8 million in the prior year period).
- Cash Payments (Six Months Ended June 30, 2017):
- Pre-tax cash payments net of insurance receipts: $28.2 million (compared to $25.7 million in the prior year period).
- Liability Estimate Update: The Company extended its liability forecast period through 2059 effective December 31, 2016, recording an additional $227 million liability at that time. No further change to the estimate was warranted for the period ended June 30, 2017.
Guidance, Outlook, and Material Litigation
Management commentary focuses on the stability of the asbestos liability estimate and the status of specific high-value litigation.
- Liability Outlook: Management believes the liability estimate through 2059 is reasonable due to stabilized mesothelioma claim filings, favorable case law trends, and state legislative restrictions on claims. The Company expects cash payments to continue for years past 2059 due to the lag between filing and resolution.
- Significant Litigation Updates:
- James Nelson (PA): The Pennsylvania Supreme Court denied plaintiffs' petition for leave to appeal in June 2017. The case may be set for a new trial in 2018.
- Geoffrey Anisansel (NY): A $20 million verdict was entered on June 30, 2017. The Company plans to file post-trial motions and appeals; this amount is not yet included in incurred costs.
- James Poage (MO): A Missouri Court of Appeals affirmed a $10.8 million judgment in May 2017. The Company has sought leave to appeal to the Supreme Court of Missouri.
- Richard DeLisle (FL): The Florida Supreme Court granted plaintiffs' motion for review in July 2017 regarding a $1.3 million judgment previously reversed in the Company's favor.
- Valent Rabovsky (PA): The Company is pursuing an appeal to the Third Circuit Court of Appeals regarding a $0.4 million judgment.
- Risks and Uncertainties: The Company notes significant uncertainties regarding the ultimate exposure, including variables in claim timing, severity, and resolution. Changes in case law, legislation, or the number of claims could materially affect the estimated liability and insurance recoveries.
Investor Verification Checklist
- Verify the full quarterly financial results (Revenue, Net Income, EPS) in Exhibit 99.1, as this 8-K summary focuses exclusively on asbestos liabilities.
- Monitor the status of the Geoffrey Anisansel claim ($20M verdict) and James Poage appeal ($10.8M judgment) for potential future cash outflows.
- Review the "coverage-in-place" agreements with excess insurers to understand the reliability of the $129 million insurance receivable asset.
- Assess the impact of the extended liability forecast period (through 2059) on long-term cash flow projections.
- Track the number of new mesothelioma claims filed, as this is cited as a primary driver of the liability estimate.